JPS59108761A - Preparation of cystamine sulfate - Google Patents

Preparation of cystamine sulfate

Info

Publication number
JPS59108761A
JPS59108761A JP21706782A JP21706782A JPS59108761A JP S59108761 A JPS59108761 A JP S59108761A JP 21706782 A JP21706782 A JP 21706782A JP 21706782 A JP21706782 A JP 21706782A JP S59108761 A JPS59108761 A JP S59108761A
Authority
JP
Japan
Prior art keywords
cystamine
sulfate
cysteamine
solution
aqueous solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP21706782A
Other languages
Japanese (ja)
Inventor
Michio Tsuchiya
土屋 美智雄
Yutaka Morimoto
豊 森本
Akihiro Sawamura
澤村 明広
Futoshi Kitagawa
北川 太
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Shokubai Co Ltd
Original Assignee
Nippon Shokubai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shokubai Co Ltd filed Critical Nippon Shokubai Co Ltd
Priority to JP21706782A priority Critical patent/JPS59108761A/en
Publication of JPS59108761A publication Critical patent/JPS59108761A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE:To crystallize and separate the titled compound in high yield and purity, easily, in high efficiency, without producing by-products, by adding hydrogen peroxide to an aqueous solution of cysteamine, adding sulfuric acid to the mixture to obtain an aqueous solution of cystamine sulfate, and adding a specific alcohol thereto. CONSTITUTION:An aqueous solution of cysteamine (having a cysteamine concentration of 20-70wt%, preferably 30-60wt%) is oxidized with hydrogen peroxide. The obtained cystamine solution is added with sulfuric acid to obtain an aqueous solution of cystamine sulfate. Cystamine sulfate is crystallized and separated from the solution by adding a 1-4C lower aliphatic alcohol (e.g. methyl, ethyl or n-propyl alcohol) to the solution preferably in an amount to give a cystamine sulfate concentration of 20-30wt% after the addition of said alcohol. The process is economically advantageous e.g. because it requires only a moderate amount of the alcohol.

Description

【発明の詳細な説明】 本発明は高純度シスタミン硫酸塩を効率良く製造する方
法に関するものである。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for efficiently producing high purity cystamine sulfate.

シスタミン硫酸塩の製造方法として、例えば特開昭55
−127360号明細書記載の方法がある。この従来公
知の方法は、システアミン塩酸塩水溶液をアルカリ(例
えば水酸化ナトリウム)で中和し、過酸化水素を加えて
酸化しシスタミン水溶液とし、濃縮した後低級脂肪族ア
ルコールに溶解させ、その際晶出する副生塩(例えば塩
化ナトリウム)を戸別除去し、次いでシスタミンのアル
コール性液に研酸を滴下し目的とするシスタミン硫酸塩
を晶出分離するものである。しかし、シスタミンのアル
コール性液に傭酸を加えたのでは副生物が生成し、シス
タミン硫酸塩晶出時に当該副生物を含むこととなり、着
色し純度の低いものになってしまう欠点を持っている。
As a method for producing cystamine sulfate, for example, JP-A-55
There is a method described in the specification of No.-127360. This conventionally known method involves neutralizing an aqueous solution of cysteamine hydrochloride with an alkali (e.g., sodium hydroxide), adding hydrogen peroxide to oxidize it to obtain an aqueous cystamine solution, concentrating it, and then dissolving it in a lower aliphatic alcohol. The resulting by-product salts (eg, sodium chloride) are removed one by one, and then abrasive acid is added dropwise to the alcoholic solution of cystamine to crystallize and separate the desired cystamine sulfate. However, when mercenic acid is added to the alcoholic solution of cystamine, by-products are generated, and when cystamine sulfate is crystallized, it contains the by-products, resulting in color and low purity. .

又、システアミン塩酸塩の脱塩酸工程、システアミン水
溶液の濃縮工程、副生塩(例えば塩化ナトリウム)の除
去工程などの多くの工程を必要としている。更に、脱塩
酸によシ生成する副生塩(例えば塩化ナトリウム)の除
去を完全に行なうことが困難であることから、製品への
混入は避けられず、この点からも純度低下の原因を持っ
ている。
In addition, many steps are required, such as a dehydrochlorination step for cysteamine hydrochloride, a step for concentrating an aqueous cysteamine solution, and a step for removing by-product salts (eg, sodium chloride). Furthermore, since it is difficult to completely remove by-product salts (e.g., sodium chloride) produced by dehydrochloric acid, their contamination with the product is unavoidable, which also causes a decrease in purity. ing.

本発明者らは、従来方法の欠点を克服し、高純度ンスタ
ミン硫酸塩を製造する方法について鋭意研9?、シた結
果、比較的高濃度のシステアミン水性液を過酸化水素で
酸化しシスタミン水溶液とし、それに硫酸を加えてンス
タミン砧酸塩水溶液とした後、炭素数1乃至4の低級脂
肪族アルコールを加えてシスタミン硫酸塩を晶出させ分
離することにより高純度シスタミン硫酸塩を収率良く簡
単な工程で製造できることを見出して本発明を完成させ
たものである。
The present inventors have conducted extensive research on a method to overcome the drawbacks of conventional methods and produce high-purity nstamin sulfate. As a result, a relatively high concentration cysteamine aqueous solution was oxidized with hydrogen peroxide to obtain a cystamine aqueous solution, sulfuric acid was added to it to obtain a cystamine aqueous solution, and then a lower aliphatic alcohol having 1 to 4 carbon atoms was added. The present invention was completed based on the discovery that high-purity cystamine sulfate can be produced in high yield and in a simple process by crystallizing and separating cystamine sulfate.

本発明の製造方法は、システアミン水性液に過酸化水素
を加えて酸化反応せしめて得られたシスタミン水溶液に
硫酸を加えて/スタミン硫酸塩水溶液とした後、炭素数
1乃至4の低級脂肪族アルコールを加えてシスタミン硫
酸塩を晶出させ分離することを特徴とするものである。
The production method of the present invention involves adding sulfuric acid to an aqueous cysteamine solution obtained by adding hydrogen peroxide to an aqueous cysteamine solution and causing an oxidation reaction to obtain an aqueous solution of stamine sulfate. is added to crystallize and separate cystamine sulfate.

システアミン水性液はシステアミンと水とから成るもの
で、例えばシステアミンと水を混合することにより容易
に調製することができる。この際、システアミン濃度に
関しては特に制限はないが、例えば20〜70重量係、
好ましくは30〜60重量係の範囲とすることができる
。比較的高濃度ではシステアミン水性液はスラリー状態
となるが、スラリー状態のシステアミン水性液を有効に
使用できる。そして、高濃度とすることにより、シスタ
ミン硫酸塩晶出段階での収率を高めることができる。
The cysteamine aqueous solution consists of cysteamine and water, and can be easily prepared, for example, by mixing cysteamine and water. At this time, there is no particular restriction regarding the cysteamine concentration, but for example, 20 to 70% by weight,
Preferably, it can be in the range of 30-60% by weight. At relatively high concentrations, the cysteamine aqueous solution becomes a slurry, but the cysteamine aqueous solution in a slurry state can be used effectively. By increasing the concentration, the yield at the cystamine sulfate crystallization step can be increased.

システアミンの履歴について(は制限がなく、種々の方
法、例えば特開昭55−111459号明細書記載の方
法、即ち「1価の低級アルコールを溶媒とし、反応系の
圧力を1.5に9/α2G以上に保チ、−10〜+40
℃の温IW範囲内で、エチレンイミン1モルに対して硫
化水素1.5モル以上の比率に保ちながら反応させる」
方法や、特開昭55−11506号、特公昭53−33
65号々どの明細書に記載された方法に従って製造され
た7ステアミンを有効にに使用することができる。
Regarding the history of cysteamine (there are no restrictions), there are various methods, such as the method described in JP-A-55-111459, ``using a monohydric lower alcohol as a solvent and reducing the pressure of the reaction system to 1.5 to 9/9. Hold above α2G, -10 to +40
The reaction is carried out within the temperature IW range of ℃ while maintaining the ratio of 1.5 moles or more of hydrogen sulfide to 1 mole of ethyleneimine.
Method, JP-A-55-11506, JP-A-53-33
7-steamine prepared according to the method described in No. 65 can be effectively used.

シスタミン水溶液は、システアミン水性液に過酸化水素
を加え0〜60℃の範囲の温度で酸化反応せしめること
により調製されたものである。この際、未反応システア
ミン濃度が1重量子以下になる丑で酸化反応を行なうこ
とが好ましい。スラリー状態の比較的高濃度のシステア
ミン水性液は、酸化反応の進行に従って均一な水溶液に
なる。過酸化水素については特に制限はなく、市販のも
の、例えば35重量係濃度の過酸化水素水溶液を用いる
のが便利である。例えば50重量係濃度のスラリー状態
システアミン水性液に35重量係濃度の過酸化水素水溶
液を加えて酸化反応せしめることにより、約35Ji量
係濃度のシスタミン水溶液を調製し、当該濃度のシスタ
ミン水溶液を用いると以後の工程に於る操作を容易にし
がっ高収率で高純度のシスタミン硫酸塩を晶出させるこ
とができるので好適である。
The cystamine aqueous solution was prepared by adding hydrogen peroxide to the cysteamine aqueous solution and causing an oxidation reaction at a temperature in the range of 0 to 60°C. At this time, it is preferable to carry out the oxidation reaction in such a manner that the concentration of unreacted cysteamine is one weight molecule or less. A relatively highly concentrated cysteamine aqueous solution in a slurry state becomes a homogeneous aqueous solution as the oxidation reaction progresses. There are no particular restrictions on hydrogen peroxide, and it is convenient to use commercially available hydrogen peroxide, for example, an aqueous hydrogen peroxide solution with a concentration of 35% by weight. For example, if an aqueous cystamine solution having a concentration of about 35 Ji is prepared by adding an aqueous hydrogen peroxide solution having a concentration of 35 by weight to a cysteamine aqueous solution in a slurry state having a concentration of 50 by weight, and causing an oxidation reaction, an aqueous cystamine solution having a concentration of about 35 Ji is used. This method is suitable because cystamine sulfate can be crystallized with high yield and purity while facilitating operations in subsequent steps.

シスタミン硫酸塩水溶液は、上記の如き比較的高濃度の
シスタミン水溶液に硫酸を加えることにより、即ち水媒
体中でシスタミンを硫酸で中和することによシ調製され
るものである。この際、中和温度を50℃以下とするの
が好ましい。このように、中和反応を水媒体中で行なう
ので、比較的高濃度のシスタミン水溶液を用いるにもが
がわらず、副生物の生成は皆無に近いものである。
The cystamine sulfate aqueous solution is prepared by adding sulfuric acid to a relatively highly concentrated cystamine aqueous solution as described above, that is, by neutralizing cystamine with sulfuric acid in an aqueous medium. At this time, it is preferable to set the neutralization temperature to 50°C or less. As described above, since the neutralization reaction is carried out in an aqueous medium, almost no by-products are produced, even though a relatively high concentration cystamine aqueous solution is used.

シスタミン硫酸塩の晶出は、上記の如き比較的高濃度の
シスタミン硫酸塩水溶液に、例えば35重量係以上の濃
度のシスタミン硫酸塩水溶液に炭素数1乃至4の低級脂
肪族アルコールを加えることにより行なうものである。
Crystallization of cystamine sulfate is carried out by adding a lower aliphatic alcohol having 1 to 4 carbon atoms to a relatively high concentration cystamine sulfate aqueous solution as described above, for example, to a cystamine sulfate aqueous solution having a concentration of 35 weight coefficient or more. It is something.

この際、系の温度は、0〜6,0℃の範囲とするのが好
ましい。該アルコールの使用量は、該アルコール添加後
のシスタミン硫酸塩濃度が20〜30重量係の範囲にな
るような量にするのが好ましい。20重量係未満になる
ような多量の該アルコールを用いたのでは、シスタミン
硫酸塩の涙液中に移行する分が多くなるので好ましくな
い。又、系の容積の割に生産量が少なくなるので好まし
くない。逆に30重量係を越えるような少量の該アルコ
ールを用いたのでは、晶出したシスタミン硫酸塩がペー
スト状になり易く、ペースト状になってしまうと炉別操
作が困難になるので好ましくない。該アルコールとして
は、例tハメーy−ルアルコール、エチルアルコール、
n−フロビルアルコール、インフロビルアルコール、ブ
チルアルコールなどを挙げることができる。
At this time, the temperature of the system is preferably in the range of 0 to 6.0°C. The amount of alcohol used is preferably such that the concentration of cystamine sulfate after addition of the alcohol is in the range of 20 to 30% by weight. If a large amount of the alcohol is used, such as less than 20% by weight, a large amount of cystamine sulfate will migrate into the lachrymal fluid, which is not preferable. Furthermore, the production volume is undesirably small compared to the volume of the system. On the other hand, if a small amount of the alcohol exceeding 30% by weight is used, the crystallized cystamine sulfate tends to become paste-like, and if it becomes paste-like, it becomes difficult to separate the reactor, which is not preferable. Examples of the alcohol include alcohol, ethyl alcohol,
Examples include n-flovir alcohol, inflovir alcohol, butyl alcohol, and the like.

シスクミン硫酸塩の晶出は、比較的高濃度のシスクミン
硫酸塩水溶液を用い、副生物や余分な硫酸のない条件丁
で行われるので、高純度シスタミン硫酸塩を効率良く得
ることができる。又、アルコール使用量も適量で済むこ
とから、経済的である。
Since the crystallization of cyscumine sulfate is carried out using an aqueous solution of ciscumine sulfate with a relatively high concentration and under conditions free of by-products and excess sulfuric acid, highly purified cystamine sulfate can be obtained efficiently. Moreover, since only a suitable amount of alcohol is used, it is economical.

晶出したシスタミン硫酸塩は、炉別することにより、系
より容易に分離することができる。炉液は、次の晶出操
作に於るアルコールとして有効に再利用できるものであ
る。分離後、減圧下で約70℃の温度で乾燥すると、白
色でサラサラした結晶のシスタミン硫酸塩が得られる。
The crystallized cystamine sulfate can be easily separated from the system by furnace separation. The furnace liquid can be effectively reused as alcohol in the next crystallization operation. After separation, it is dried under reduced pressure at a temperature of about 70°C to obtain cystamine sulfate in the form of white, smooth crystals.

このものは、減圧下での乾燥減量が6〜7重量係の範囲
にあることから、恐らくシスタミン硫酸1水塩になって
いるものと考えられる。しかし、このような結晶形だけ
で本発明が制限されるものではない。
Since the loss on drying under reduced pressure is in the range of 6 to 7 weight percent, this product is probably cystamine sulfate monohydrate. However, the present invention is not limited only to such crystal forms.

以下、実施例により本発明を更に詳しく説明する。Hereinafter, the present invention will be explained in more detail with reference to Examples.

実施例 1 システアミン170?と水]、 70 rを混合し、濃
度50重重量%スラリー状シスチアミン水溶液を得た。
Example 1 Cysteamine 170? and water] and 70 r were mixed to obtain an aqueous cystyamine slurry solution having a concentration of 50% by weight.

この水溶液に35重量係濃度の過酸化水素水溶液を加え
35℃以下の温度に保ちながら酸化反応せしめた。酸化
反応は、ヨウ素滴定法により−SH基量を測定し、未反
応システアミン濃度が0.1重量%以下となるまで進め
た。シスタミン水溶液4642が得られた。臭素酸カリ
法により一8s−基を分析しシスタミン濃度を測定した
ところ35.9重量%であり、収率は99.3係であっ
た。
An aqueous hydrogen peroxide solution having a concentration of 35% by weight was added to this aqueous solution, and an oxidation reaction was carried out while maintaining the temperature at 35° C. or lower. The oxidation reaction was carried out until the concentration of unreacted cysteamine was 0.1% by weight or less, by measuring the amount of -SH groups by iodometric titration. Cystamine aqueous solution 4642 was obtained. The cystamine concentration was measured by analyzing the -8s- group by the potassium bromate method and found to be 35.9% by weight, and the yield was 99.3%.

シスタミン水溶液3762に、攪拌下、50℃以下の温
度に保ちながら、濃硫酸932(硫e 1.1モル/シ
スタミン1モル)ヲ加えシスタミン硫酸塩水溶液を得た
Concentrated sulfuric acid 932 (1.1 mol of sulfuric acid/1 mol of cystamine) was added to cystamine aqueous solution 3762 while stirring and keeping the temperature below 50° C. to obtain an aqueous cystamine sulfate solution.

このようにして得たシスタミン硫酸塩水溶液にメチルア
ルコール42o?を加え、系を24℃の温度に冷却して
シスタミン硫酸塩を晶出させた。
The cystamine sulfate aqueous solution thus obtained was mixed with methyl alcohol 42o? was added and the system was cooled to a temperature of 24°C to crystallize cystamine sulfate.

戸別し、70℃の温度で減圧乾燥し、白色のシスタミン
硫酸塩結晶を得た。収率は94.4係であった。純度は
、99.6係であった。
The mixture was separated and dried under reduced pressure at a temperature of 70°C to obtain white cystamine sulfate crystals. The yield was 94.4%. The purity was 99.6.

実施例 2 システアミン1709と水35o?を混合し、システア
ミン水溶液を得た。この水溶液に、35M量係濃濃度過
酸化水素水溶液を加え、35℃以下の温度に保ちながら
酸化反応せしめた。酸化反応は、未反応システアミン濃
度が0.1重量%以下となるまで進めた。26.0重量
温度度の7スタミン水溶液639ノを得た。収率は、9
9循であった。この水溶液に、攪拌下、50’C以下の
温度に保ちながら、濃硫酸102″?(硫酸0.95モ
ル/シスタミン1モル)を加えシスタミン硫酸塩水溶液
を得た。
Example 2 Cysteamine 1709 and water 35o? were mixed to obtain an aqueous cysteamine solution. A 35M concentrated hydrogen peroxide aqueous solution was added to this aqueous solution, and an oxidation reaction was carried out while maintaining the temperature at 35° C. or lower. The oxidation reaction was continued until the concentration of unreacted cysteamine was 0.1% by weight or less. 639 pieces of 7stamine aqueous solution having a weight temperature of 26.0 kg were obtained. The yield is 9
It was the 9th cycle. To this aqueous solution was added concentrated sulfuric acid (0.95 mol of sulfuric acid/1 mol of cystamine) to obtain an aqueous solution of cystamine sulfate while stirring and keeping the temperature below 50'C.

このようにして得たシスクミン硫酸塩水溶液にインフロ
ビルアルコール500?を加え、系を15℃の温度に冷
却してシスタミン硫酸塩を晶出させた。戸別し、70℃
の温度で減圧乾燥し、白色のシスタミン硫酸塩結晶を得
た。収率は、89.3係であった。純度は99.2 %
であった。
Inflovir alcohol 500? was added and the system was cooled to a temperature of 15°C to crystallize cystamine sulfate. Door to door, 70℃
The mixture was dried under reduced pressure at a temperature of 100 to obtain white cystamine sulfate crystals. The yield was 89.3%. Purity is 99.2%
Met.

比較例 1 シスタミン水溶液を減圧下、60’Cの温度で濃縮し、
85重量係濃度のシスタミン水溶液を得だ。
Comparative Example 1 Cystamine aqueous solution was concentrated under reduced pressure at a temperature of 60'C,
An aqueous cystamine solution having a concentration of 85% by weight was obtained.

これに4倍量のインプロビルアルコールヲ加えた。To this was added 4 times the amount of Improvil alcohol.

次いで攪拌下、40℃以下の温度に保ちながら硫酸をシ
スタミンに対して等モル量を滴下した。硫酸滴下と同時
にシスタミン儲e塩が晶出し、系が白濁した。戸別し、
70℃の温度で減圧乾燥し、黄色のシスタミン硫酸塩結
晶を得た。収率は60循と低く、又純度も78係と低く
かった。
Next, sulfuric acid was added dropwise in an equimolar amount to cystamine while stirring and maintaining the temperature at 40° C. or lower. At the same time as the sulfuric acid was added, cystamine salt crystallized and the system became cloudy. going door to door,
It was dried under reduced pressure at a temperature of 70°C to obtain yellow cystamine sulfate crystals. The yield was low at 60 cycles, and the purity was also low at 78 cycles.

Claims (1)

【特許請求の範囲】 1、 システアミン水性液に過酸化水素を加え酸−化反
応せしめて得られたシスタミン水溶液に研酸を加えてシ
スタミン硫酸塩水溶液とした後、炭素数1乃至4の低級
脂肪族アルコールを加えてシスタミン水溶液塩を晶出さ
せ分離することを特徴とするシスタミン硫酸塩の製造方
法。 2、システアミン水性液はシステアミン濃度が20〜7
0重量幅の範囲にある特許請求の範囲第1項記載の製造
方法。
[Scope of Claims] 1. Hydrogen peroxide is added to an aqueous cysteamine solution to cause an acidification reaction, and a polishing acid is added to an aqueous cystamine solution to obtain an aqueous cystamine sulfate solution. A method for producing cystamine sulfate, which comprises adding a group alcohol to crystallize and separate an aqueous cystamine salt. 2. The cysteamine aqueous solution has a cysteamine concentration of 20 to 7.
The manufacturing method according to claim 1, wherein the weight range is 0.
JP21706782A 1982-12-13 1982-12-13 Preparation of cystamine sulfate Pending JPS59108761A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP21706782A JPS59108761A (en) 1982-12-13 1982-12-13 Preparation of cystamine sulfate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21706782A JPS59108761A (en) 1982-12-13 1982-12-13 Preparation of cystamine sulfate

Publications (1)

Publication Number Publication Date
JPS59108761A true JPS59108761A (en) 1984-06-23

Family

ID=16698311

Family Applications (1)

Application Number Title Priority Date Filing Date
JP21706782A Pending JPS59108761A (en) 1982-12-13 1982-12-13 Preparation of cystamine sulfate

Country Status (1)

Country Link
JP (1) JPS59108761A (en)

Similar Documents

Publication Publication Date Title
JPS59108761A (en) Preparation of cystamine sulfate
JP2000302748A (en) Method for purifying sulfonimide
JP3003287B2 (en) Method for producing sodium N-alkylaminoethanesulfonate
JPH10306072A (en) Separation of ammonium sulfate and ammonium bisulfate and production of 2-hydroxy-4-methylthiobutanoic acid using the same
US5847205A (en) Method for producing homocystine
JPS59110667A (en) Production of cystamine sulfate
RU2404159C2 (en) Method for synthesis of dihydrate of 3-(2,2,2-trimethylhydrazinium)-propionate
US3317588A (en) Process of purifying cyclohexyl-ammonium-n-cyclohexylsulfamate contaminated with cyclohexylamine sulfate
JPH08291135A (en) Production of taurine analog
JPH04506519A (en) Process for producing light-colored lower alkanesulfonic acids, especially methanesulfonic acid
US3772374A (en) Process for preparing alkali metal nitrilotriacetates
JPH01193245A (en) Production of s-carboxymethyl-l-cysteine
JPH0413657A (en) Production of 2,4-diaminobenzenesulfonic acid
JPH01153654A (en) Production of ammonium fluorine-containing carboxylate
JPS59108760A (en) Preparation of cystamine sulfate
JP3003288B2 (en) Method for producing sodium N-alkylaminoethanesulfonate
US3355485A (en) Preparation of sodium cyclohexyl sulfamate free of sulfate ions
JP2005067944A (en) Method for producing iodic acid
JPH08268995A (en) Production of aminoalkylsulfonates
JPS629522B2 (en)
JPH04506520A (en) Method for producing lower alkanesulfonic acid from its alkali metal salt
JPS5874525A (en) Separation of arsenious acid and gypsum from acidic aqueous solution of sulfuric acid containing arsenious acid and gypsum
JPH0656758A (en) Production of 2-naphthol-6-sulfonate
JPS63188675A (en) Production of sultone
JPH01190661A (en) Purification of 4,4'-dihydroxydiphenylsulfone